M. Orrù

发表

Overview of elagolix for the treatment of endometriosis

A. Paoletti, S. Guerriero, M. D'Alterio, 2016, Expert opinion on drug metabolism & toxicology.

Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women.

A. Paoletti, A. Cagnacci, A. Volpe, 2002, The Journal of clinical endocrinology and metabolism.

Reproductive Endocrinology: Uterine Perfusion and Hormonal Pattern in Patients with Polycystic Ovary Syndrome

A. Paoletti, S. Guerriero, S. Ajossa, 2001, Journal of Assisted Reproduction and Genetics.

Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.

A. Paoletti, S. Guerriero, S. Ajossa, 2000, Contraception.

Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.

A. Paoletti, R. Sorge, S. Guerriero, 2004, Contraception.

Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report

R. Berria, A. Paoletti, G. Melis, 2008, Reproductive biology and endocrinology : RB&E.

Observational study on the efficacy of the supplementation with a preparation with several minerals and vitamins in improving mood and behaviour of healthy puerperal women

A. Paoletti, R. Sorge, G. Melis, 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome

A. Paoletti, S. Guerriero, S. Ajossa, 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Melatonin enhances the luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the follicular, but not in the luteal, menstrual phase.

A. Paoletti, A. Cagnacci, G. Melis, 1995, The Journal of clinical endocrinology and metabolism.

Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies

A. Paoletti, S. Guerriero, S. Ajossa, 1995, Journal of Assisted Reproduction and Genetics.

Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.

A. Paoletti, S. Guerriero, S. Ajossa, 1999, Fertility and sterility.

The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome.

A. Paoletti, S. Guerriero, S. Ajossa, 2002, Fertility and sterility.

Use of oral contraceptives in the management of acne

A. Paoletti, G. Melis, S. Lello, 2011 .

Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study

A. Paoletti, A. Cagnacci, G. Melis, 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.

A. Paoletti, A. Cagnacci, A. Volpe, 2003, The Journal of clinical endocrinology and metabolism.

Risk management in obstetrics: how to reduce the risk?

A. Paoletti, B. Piras, M. Neri, 2015 .

Pattern of Bone Markers during Pregnancy and Their Changes after Delivery

A. Paoletti, S. Guerriero, S. Ajossa, 2003, Hormone Research in Paediatrics.

Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity

G. Biggio, A. Paoletti, A. Concas, 2006, Psychoneuroendocrinology.

The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome.

S. Ajossa, A. Cagnacci, G. Melis, 1996, Fertility and sterility.

Epidemiology of Epithelial Ovarian Carcinoma

A. Paoletti, G. Melis, B. Piras, 2013 .

Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause.

A. Paoletti, G. Melis, S. Floris, 2001, The Journal of clinical endocrinology and metabolism.

Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome.

S. Ajossa, A. Cagnacci, G. Melis, 1995, Fertility and sterility.

Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy.

A. Paoletti, S. Guerriero, S. Ajossa, 2001 .

Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment

A. Paoletti, S. Guerriero, G. Melis, 2012, Expert opinion on drug metabolism & toxicology.

Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome.

S. Guerriero, S. Ajossa, G. Melis, 2001, Journal of assisted reproduction and genetics.

Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy.

A. Paoletti, G. Melis, B. Piras, 2007, Fertility and sterility.

Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation

A. Paoletti, A. Cagnacci, G. Melis, 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.

A. Paoletti, R. Sorge, S. Guerriero, 2010, Contraception.

Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass.

A. Paoletti, G. Melis, S. Lello, 2009, Contraception.

The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study.

A. Paoletti, A. Genazzani, R. Sorge, 2007, Contraception.

Low androgenization index in elderly women and elderly men with Alzheimer’s disease

M. Pistis, A. Paoletti, G. Melis, 2004, Neurology.

Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel.

M. Pistis, A. Paoletti, S. Guerriero, 2002, Maturitas.

Observational Study on the Efficacy of Tibolone in Counteracting Early Carotid Atherosclerotic Lesions in Postmenopausal Women

A. Paoletti, G. Melis, F. Binaghi, 2004, Hormone Research in Paediatrics.